JPMorgan’s $30 target on PFE

PFE Pfizer

$28.3 → $30 (+6%) by Oct 2027

Neutral · raises · said Oct 10, 2026 · 12-month default horizon

Open: judged on the close on Oct 10, 2027

The article this target came from

J.P. Morgan Keeps Their Hold Rating on Pfizer (PFE)

The Globe and Mail · Oct 10, 2026

J.P. Morgan analyst Chris Schott maintained a Hold rating on Pfizer today and set a price target of $30.00.

JPMorgan’s track record → Pfizer →

A fact about what JPMorgan published, as reported by The Globe and Mail, not a recommendation from Dalsna Finance; JPMorgan is not affiliated with this site.

Full methodology: how targets are collected, scored, ranked and corrected, what each field means, and how to cite the data.